ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

Preserve NCI’s Role In Applied Research And Its Unique Environment, Chabner Says

May 12, 1995

NCAB Working Group To Hold Open And Closed Sessions

January 20, 1995

NCAB Removes Its Restrictions On PDQ Access, Permits NCI Staff To Decide

February 7, 1986

In Brief: Cavenee Is President-elect of AACR; Coffey To Succeed Strong As President

April 11, 1997

Cervical Cancer Screening Can Be Done Later, Less Often

December 25, 2009

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

December 28, 2012